IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 3.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $58,000 | -92.9% | 43,799 | -90.2% | 0.00% | -100.0% |
| Q1 2018 | $821,000 | +1268.3% | 446,286 | +1461.4% | 0.00% | – |
| Q4 2017 | $60,000 | -50.0% | 28,583 | -46.9% | 0.00% | – |
| Q3 2017 | $120,000 | – | 53,786 | +55927.1% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 96 | -82.9% | 0.00% | – |
| Q1 2017 | $1,000 | -66.7% | 563 | -71.2% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 1,953 | +175.5% | 0.00% | – |
| Q3 2016 | $2,000 | – | 709 | +17625.0% | 0.00% | – |
| Q2 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 4 | -99.3% | 0.00% | – |
| Q3 2015 | $1,000 | -83.3% | 550 | -70.0% | 0.00% | – |
| Q2 2015 | $6,000 | -50.0% | 1,831 | -51.6% | 0.00% | – |
| Q1 2015 | $12,000 | -14.3% | 3,782 | +7.5% | 0.00% | – |
| Q4 2014 | $14,000 | -97.5% | 3,518 | -98.7% | 0.00% | – |
| Q3 2014 | $556,000 | -10.9% | 278,279 | -10.7% | 0.00% | -100.0% |
| Q2 2014 | $624,000 | +62300.0% | 311,794 | +120750.4% | 0.00% | – |
| Q1 2014 | $1,000 | – | 258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |